1. He, K, Song, Y, Daviglus, ML, et al. Accumulated evidence on fish consumption and cronary heart disease mortality. Circulation 2004; 109(22): 2705–2711.
Google Scholar | Crossref | Medline2. Leaf, A . Historical overview of n-3 fatty acids and coronary heart disease. Am J Clin Nutr 2008; 87(6): 1978S–1980S.
Google Scholar | Crossref | Medline3. Bang, HO, Dyerberg, J, Hjøorne, N. The composition of food consumed by Greenland Eskimos. Acta Medica Scand 1976; 200(1–2): 69–73.
Google Scholar | Medline4. Calder, PC . Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans 2017; 45(5): 1105–1115.
Google Scholar | Crossref | Medline5. Simopoulos, AP . The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 2008; 233(6): 674–688.
Google Scholar | SAGE Journals | ISI6. Peterrson, S, Philippou, E, Odoma, C, et al. The mediterranean diet, fish oil supplements and rheumatoid arthritis outcomes: evidence from clinical trials. Autoimmun Rev 2018; 17(11): 1105–1114.
Google Scholar | Crossref | Medline7. Li, X, Bi, X, Wang, S, et al. Therapeutic potential of ω-3 polyunsaturated fatty acids in human autoimmune diseases. Front Immunol 2019; 10: 2241–2256.
Google Scholar | Crossref | Medline8. Duffy, EM, Meenagh, GK, McMillan, SA, et al. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. J Rheumatol 2004; 31: 1551–1556.
Google Scholar | Medline | ISI9. Wright, SA, O'Prey, FM, McHenry, MT, et al. A randomised interventional trial of -3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis 2008; 67: 841–848.
Google Scholar | Crossref | Medline | ISI10. Arriens, C, Hynan, LS, Lerman, RH, et al. Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus. Nutr J 2015; 14: 82.
Google Scholar | Crossref | Medline11. Charoenwoodhipong, P, Harlow, SD, Marder, W, et al. Dietary omega polyunsaturated fatty acid intake and patient-reported outcomes in systemic lupus erythematosus: the Michigan lupus epidemiology and surveillance program. Arthritis Care Res 2020; 72(7): 874–881.
Google Scholar | Crossref12. Akbar, U, Yang, M, Kurian, D, et al. Omega-3 fatty acids in rheumatic diseases: a critical review. J Clin Rheumatol 2017; 23(6): 330–339.
Google Scholar | Crossref | Medline13. Lozovoy, MAB, Simão, ANC, Morimoto, HK, et al. Fish oil N-3 fatty acids increase adiponectin and decrease leptin levels in patients with systemic lupus erythematosus. Mar Drugs 2015; 13: 1071–1083
Google Scholar | Crossref | Medline14. Clark, WF, Parbtani, A, Huff, MW, et al. Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus. Kidney Int 1989; 36: 653–660.
Google Scholar | Crossref | Medline | ISI15. Clark, WF, Parbtani, A, Naylor, CD, et al. Fish oil in lupus nephritis: clinical findings and methodological implications. Kidney Int 1993; 44: 75–86.
Google Scholar | Crossref | Medline | ISI16. Nakamura, N, Kumasaka, R, Osawa, H, et al. Effects of eicosapentaenoic acids on oxidative stress and plasma fatty acid composition in patients with lupus nephritis. In Vivo 19: 879–882 (2005).
Google Scholar | Medline17. Curado Borges, MF, de Miranda Moura Dos Santos, F, Weiss Telles, R, et al. Omega-3 fatty acids, inflammatory status and biochemical markers of patients with systemic lupus erythematosus: a pilot study. Rev Bras Reumatol 2017; 57(6): 526–534.
Google Scholar18. Elkan, AC, Anania, C, Gustafsson, T, et al. Diet and fatty acid pattern among patients with SLE: associations with disease activity, blood lipids and atherosclerosis. Lupus 2012; 21: 1405–1411.
Google Scholar | SAGE Journals | ISI19. Bello, KJ, Fang, H, Fazeli, P, et al. Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus. Rheumatol Int 2013; 33: 2789–2796.
Google Scholar | Crossref | Medline20. Walton, AJ, Snaith, ML, Locniskar, M, et al. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 463–466.
Google Scholar | Crossref | Medline | ISI21. Das, UN . Essential fatty acids as possible mediators of the actions of statins. Prostaglandins Leukot Essent Fatty Acids 2001; 65(1): 37–40.
Google Scholar | Crossref | Medline22. Yang, ZH, Amar, M, Sampson, M, et al. Comparison of omega-3 eicosapentaenoic acid versus docosahexaenoic acid-rich fish oil supplementation on plasma lipids and lipoproteins in normolipidemic adults. Nutrients 2020; 12(3): 749. DOI: 10.3390/nu12030749.
Google Scholar | Crossref23. Bhatt, DL, Steg, PG, Miller, M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. New Engl J Med 2019; 380: 11–22.
Google Scholar | Crossref | Medline24. Nicholls, SJ, Lincoff, AM, Garcia, M, et al. Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk. JAMA 2020; 324(22): 2268–2280.
Google Scholar | Crossref | Medline25. Akbar, U, Yang, M, Kurian, D, et al. Omega-3 fatty acids in rheumatic diseases. J Clin Rheumatol 2017; 23: 330–339.
Google Scholar | Crossref | Medline26. Wang, DG, Tang, XW, Fan, Y, et al. Decreased flow-mediated dilatation in patients with systemic lupus erythematosus: a meta-analysis. Inflammation 2014; 37(6): 2067–2075.
Google Scholar | Crossref | Medline | ISI27. Costenbader, K, Hahn, J, Cook, N, et al. Vitamin D and marine n-3 fatty acid supplementation and prevention of autoimmune disease in the VITAL randomized controlled trial.ACR convergence.2021
Google Scholar28. Navarra, SV, Guzmán, RM, Gallacher, AE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 2011; 377(9767): 721–731.
Google Scholar | Crossref | Medline | ISI29. Morand, EF, Furie, R, Tanaka, Y, et al. Trial of anifrolumab in active systemic lupus erythematosus. New Engl J Med 2020; 382: 211–221.
Google Scholar | Crossref | Medline